Hydrochlorothiazide and Ornithine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydrochlorothiazide (hydrochlorothiazide) and Ornithine (ornithine). Common drug interactions include contusion among females and chills among males.

The phase IV clinical study analyzes what interactions people have when they take Hydrochlorothiazide and Ornithine. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Hydrochlorothiazide?

Hydrochlorothiazide has active ingredients of hydrochlorothiazide. It is often used in high blood pressure. eHealthMe is studying from 182,194 Hydrochlorothiazide users. Check the latest studies of Hydrochlorothiazide.

What is Ornithine?

Ornithine has active ingredients of ornithine. eHealthMe is studying from 591 Ornithine users. Check the latest studies of Ornithine.

On Jul, 10, 2026

11 people who take Hydrochlorothiazide and Ornithine together, and have interactions are studied.

Hydrochlorothiazide and Ornithine drug interactions.

What are the common drug interactions of Hydrochlorothiazide and Ornithine, by gender? *:

female:

Contusion (a type of hematoma of tissue in which capillaries)
Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
Drug ineffective
Fall
Gait disturbance
Glaucoma (increased fluid pressure in the eye with vision loss)
Human papilloma virus test positive
Hypoaesthesia (reduced sense of touch or sensation)
Joint lock
Laceration (tearing of soft body tissue)

male:

Chills (felling of cold)
Neutropenia (an abnormally low number of neutrophils)
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Fall
Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
Haemorrhage intracranial (bleeding within the skull)

What are the common drug interactions of Hydrochlorothiazide and Ornithine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Alopecia (absence of hair from areas of the body)
Back pain
Balance disorder
Contusion (a type of hematoma of tissue in which capillaries)
Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
Drug ineffective
Fall
Gait disturbance
Glaucoma (increased fluid pressure in the eye with vision loss)
Human papilloma virus test positive

60+:

Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
Fall
Haemorrhage intracranial (bleeding within the skull)
Hyperglycaemia (high blood sugar)
Pneumonia
Weight decreased

What are the existing conditions these people have? *

Insomnia (sleeplessness): 4 people, 36.36%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 36.36%
Burkitt Lymphoma (cancer of the lymphatic system): 4 people, 36.36%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 18.18%
Gait Disturbance: 2 people, 18.18%
Abdominal Pain: 2 people, 18.18%
Procedural Pain: 1 person, 9.09%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 9.09%
Multiple Myeloma (cancer of the plasma cells): 1 person, 9.09%
Local Anaesthesia: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Hydrochlorothiazide and Ornithine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously